Details
Description
This presentation discusses the implementation of the CONSIGN study (COVID-19 Infection and Medicines in Pregnancy) to assess the prevalence of medication use and characterize severity and clinical outcomes in pregnancies with COVID-19 compared to those without COVID-19 and reproductive-aged patients with COVID-19. It was presented at the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Additional Information
Contributors
Presenter(s)
Mayura Shinde, Jennifer G. Lyons, Susan Andrade, Austin Cosgrove, Jolene Damon, Elizabeth Messenger-Jones, Danijela Stojanovic, Ben Wong, Leyla Sahin, Yueqin Zhao, Darren Toh, Wei Hua